← Browse by Condition
Medical Condition
myocardial infarction
Total Trials
11
Recruiting Now
11
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for myocardial infarction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — myocardial infarction Clinical Trials
How many clinical trials are currently recruiting for myocardial infarction?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for myocardial infarction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for myocardial infarction?
myocardial infarction research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a myocardial infarction clinical trial?
Eligibility criteria for myocardial infarction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06701968
Recruiting
Enrollment
150 pts
Location
Sweden
Sponsor
Uppsala University
NCT05272618
Recruiting
Enrollment
150 pts
Location
South Korea
Sponsor
Chonnam National University Ho...
NCT03854071
Recruiting
Enrollment
135 pts
Location
United Kingdom
Sponsor
Sheffield Teaching Hospitals N...
NCT03908463
Recruiting
Enrollment
20,000 pts
Location
South Korea
Sponsor
Yonsei University
NCT06486233
Recruiting
Enrollment
385 pts
Location
Vietnam
Sponsor
Gia Dinh People Hospital
NCT05665608
Recruiting
Enrollment
3,595 pts
Location
Austria, Belgium, Cz...
Sponsor
Charite University, Berlin, Ge...
NCT05519735
Recruiting
Enrollment
57 pts
Location
Germany
Sponsor
Wuerzburg University Hospital
NCT04988672
Recruiting
Enrollment
4,000 pts
Location
Switzerland
Sponsor
Luzerner Kantonsspital
NCT05339477
Recruiting
Enrollment
4,000 pts
Location
Sweden
Sponsor
Sahlgrenska University Hospita...
NCT06128993
Recruiting
Enrollment
60 pts
Location
United Kingdom
Sponsor
Royal Brompton & Harefield NHS...
NCT00794001
Recruiting
Enrollment
50,000 pts
Location
Germany
Sponsor
Karl Heinrich Scholz
Related Conditions
coronary artery disease (2) coronary disease (1) coronary arteriosclerosis (1) chronic coronary syndrome (1) masld (1) type 2 diabetes (1) coronary microvascular dysfunction (1) vasospasm coronary (1) heart failure (1) pulmonary hypertension (1) acute coronary syndrome (1) percutaneous coronary intervention (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology